人类心力衰竭不良结果的蛋白质组关联
Marie-Joe Dib1,2, Michael G Levin1,2, Lei Zhao3
1Division of Cardiovascular Medicine Hospital of the University of Pennsylvania Philadelphia PA USA.
这项研究确定了与心力衰竭 (HF) 的不良结果相关的新型血蛋白. 这些发现表明了改善HF患者预后的潜在新治疗点.
科学领域:
- 心血管研究研究心血管研究
- 蛋白质组学是指蛋白质组学.
- 遗传学 是一个遗传学.
背景情况:
- 确定心力衰竭 (HF) 进展的新分子驱动因素对于开发新的治疗点至关重要.
- 血蛋白越来越被认为是潜在的生物标记物和心血管疾病的治疗点.
研究的目的:
- 为了研究血蛋白和HF患者的不良结果之间的关系,减少喷射分数.
- 通过使用孟德尔随机化来探索已识别的血蛋白在HF进展中的假定因果作用.
主要方法:
- 在1964年HF患者中测量了4776个血蛋白 (宾州心力衰竭研究).
- 评估了所有原因死亡和死亡或与HF相关的住院治疗 (DHFA) 的观察相关性.
- 使用2个样本的孟德尔随机化和局部化分析对显著蛋白质.
主要成果:
- 在多次测试校正后,243种蛋白质与死亡有显著关联,126种与DHFA有关.
- 发现的关键蛋白质包括死亡的GDF-15和DHFA的SP-C.
- 途径分析揭示了与纤维化,炎症和凝固途径的显著关联.
结论:
- 多种新型蛋白质与HF进展和不良结果有关.
- 初步证据表明,基因预测的17种蛋白质的血水平与HF风险有关.
更多相关视频
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
相关概念视频
Pathophysiology of Heart Failure
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
